September 29, 2018
2 min watch
Save

VIDEO: OCT measures cytokine changes in DME treatments

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VIENNA ― Javier Zarranz-Ventura, MD, PhD, discusses his presentation at the Euretina meeting in which he reviewed the use of OCT to observe cytokine changes in patients treated with anti-VEGF as well as steroids for diabetic macular edema.